Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,751-1,775 of 2,022
RecruitingNCT02639702

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
WithdrawnNCT03497299

Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Global
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
CompletedNCT03189810

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
CompletedNCT04602741

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
CompletedNCT04350775

Investigation of Community Reablement on Instrumental Activities of Daily Living in People With Schizophrenia

This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 20 Years to 99 Years
Countries
Taiwan
Sponsor
National Taipei University of Nursing and Health Sciences
Condition
Schizophrenia
TerminatedNCT03040505

Future Mental Projections in Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
CompletedNCT04280367

Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 30 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Schizophrenia
CompletedNCT05352568

Is Cognitive Training an Option?

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Alliant International University
Condition
Schizophrenia
CompletedNCT05663749

Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherOver 25 Years
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Condition
Schizophrenia
CompletedNCT04605393

Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
CompletedNCT04180709

CBT to Reduce Insomnia and Improve Social Recovery in Early Psychosis

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Cambridge
Condition
Schizophrenia
WithdrawnNCT03464162

OnTrackNY With the Option of Social Network Meetings

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand what helps a therapy or guided support program stay useful, realistic, and easier to follow over time.

SchizophreniaOtherOver 16 Years
Countries
United States
Sponsor
Lisa Dixon
Condition
Schizophrenia
CompletedNCT05986409

Indoor Artificial Light at Night and the Relapse Risk of Schizophrenia

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
China
Sponsor
Weizhuo Yi
Condition
Schizophrenia
CompletedNCT04309370

Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia

This study exists to see whether brain scans or other body measurements is workable and worth testing more broadly. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
CompletedNCT04182113

rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia

This study exists to see whether brain scans or other body measurements is workable and worth testing more broadly. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
CompletedNCT03548155

Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 62 Years
Countries
Global
Sponsor
Tianjin Anding Hospital
Condition
Schizophrenia
CompletedNCT05759091

Effect of Applying Cognitive Defusion Techniques on Mindful Awareness, Cognitive Fusion and Believability of Delusions Among Clients With Schizophrenia

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOther
Countries
Egypt
Sponsor
Alexandria University
Condition
Schizophrenia
Not Yet RecruitingNCT05948111

Assessment of Schizophrenia Patients' Clinical Study Experiences

This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can give earlier or clearer feedback during care.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Power Life Sciences Inc.
Condition
Schizophrenia
CompletedNCT01291511

Relapse Prevention Study in Patients With Schizophrenia

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
India, Ukraine, United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
CompletedNCT04221269

Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Schizophrenia
CompletedNCT01521026

Cognitive Training for Patients With Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia